ATE211916T1 - Entzündungshemmende faktor, methode seiner isolation und verwendung - Google Patents

Entzündungshemmende faktor, methode seiner isolation und verwendung

Info

Publication number
ATE211916T1
ATE211916T1 AT95933752T AT95933752T ATE211916T1 AT E211916 T1 ATE211916 T1 AT E211916T1 AT 95933752 T AT95933752 T AT 95933752T AT 95933752 T AT95933752 T AT 95933752T AT E211916 T1 ATE211916 T1 AT E211916T1
Authority
AT
Austria
Prior art keywords
inflammatory factor
isolation
methods
factor
cells
Prior art date
Application number
AT95933752T
Other languages
English (en)
Inventor
Lee R Beck
J Peter Fuhrer
Original Assignee
Stolle Milk Biologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Milk Biologics Inc filed Critical Stolle Milk Biologics Inc
Application granted granted Critical
Publication of ATE211916T1 publication Critical patent/ATE211916T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT95933752T 1994-10-03 1995-09-08 Entzündungshemmende faktor, methode seiner isolation und verwendung ATE211916T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/316,474 US5650175A (en) 1982-06-03 1994-10-03 Anti-inflammatory factor, method of isolation, and use
PCT/US1995/011398 WO1996010410A1 (en) 1994-10-03 1995-09-08 Anti-inflammatory factor, method of isolation, and use

Publications (1)

Publication Number Publication Date
ATE211916T1 true ATE211916T1 (de) 2002-02-15

Family

ID=23229212

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95933752T ATE211916T1 (de) 1994-10-03 1995-09-08 Entzündungshemmende faktor, methode seiner isolation und verwendung

Country Status (19)

Country Link
US (1) US5650175A (de)
EP (1) EP0787007B1 (de)
JP (2) JP4234197B2 (de)
KR (1) KR100424403B1 (de)
AT (1) ATE211916T1 (de)
AU (1) AU692608B2 (de)
CA (1) CA2201106C (de)
DE (1) DE69525060T2 (de)
DK (1) DK0787007T3 (de)
ES (1) ES2170809T3 (de)
FI (1) FI120574B (de)
HK (1) HK1000552A1 (de)
IL (1) IL115293A (de)
MX (1) MX9702398A (de)
NO (1) NO318921B1 (de)
NZ (2) NZ293763A (de)
PT (1) PT787007E (de)
TW (1) TW410157B (de)
WO (1) WO1996010410A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980953A (en) * 1994-10-03 1999-11-09 Stolle Milk Biologics, Inc. Anti-inflammatory factor, method of isolation, and use
JP2001342127A (ja) * 2000-06-02 2001-12-11 Nomoto Kikuo 腸吸収性抗炎症因子含有免疫性物質及びその応用
US6770280B1 (en) 2001-11-15 2004-08-03 Humanetics Corporation Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product
US20080206415A1 (en) * 2004-10-07 2008-08-28 Next Proteins, Inc. Protein beverage and method of making the same
US9220292B2 (en) 2004-10-07 2015-12-29 Next Problems, Inc. Protein beverage and method of making same
US20110183052A1 (en) * 2004-10-07 2011-07-28 Next Proteins, Inc. Protein beverage and method of making the same
US20070025980A1 (en) * 2005-07-27 2007-02-01 Krogsgaard David L Composition permitting muscle growth while protecting joint health
US20080026983A1 (en) * 2006-07-28 2008-01-31 Gardiner Paul T Compositions and methods for alleviating joint pain and improving joint flexibility

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128230A (en) * 1961-04-04 1964-04-07 Sunbury Milk Products Co Milk having antibodies therein and process for producing same
US3376198A (en) * 1965-07-21 1968-04-02 Collins Products Inc Method of producing antibodies in milk
GB1211876A (en) * 1967-11-23 1970-11-11 Twyford Lab Ltd Improvements in and relating to prophylactic and therapeutic preparations
CH590064A5 (de) * 1973-11-28 1977-07-29 Biokema Sa
US4324782A (en) * 1974-01-28 1982-04-13 Beck Lee R Dental caries inhibiting product of immunized cow's milk having antibodies specific to killed Streptococcus mutans cells
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
US4284623A (en) * 1979-11-09 1981-08-18 Beck Lee R Method of treating inflammation using bovine milk
DE3172807D1 (en) * 1981-04-28 1985-12-12 Stolle Res & Dev Method of obtaining an anti-inflammatory bovine milk
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
US5242691A (en) * 1982-06-03 1993-09-07 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US4897265A (en) * 1983-10-27 1990-01-30 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
US5352462A (en) * 1982-06-03 1994-10-04 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US4956349A (en) * 1983-10-27 1990-09-11 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
EP0300102B1 (de) * 1987-07-21 1993-03-24 The Stolle Research And Development Corporation Verfahren zum Erhalten von immunregulierenden Faktoren mittels Säugetierimmunisierung

Also Published As

Publication number Publication date
US5650175A (en) 1997-07-22
KR970706008A (ko) 1997-11-03
CA2201106C (en) 2010-03-23
JPH10509420A (ja) 1998-09-14
JP2008133299A (ja) 2008-06-12
DE69525060T2 (de) 2002-11-14
NO318921B1 (no) 2005-05-23
NO971474L (no) 1997-06-03
IL115293A (en) 2000-12-06
AU3628295A (en) 1996-04-26
CA2201106A1 (en) 1996-04-11
FI971245L (fi) 1997-05-28
NO971474D0 (no) 1997-04-01
FI120574B (fi) 2009-12-15
ES2170809T3 (es) 2002-08-16
EP0787007A1 (de) 1997-08-06
NZ333653A (en) 2000-08-25
WO1996010410A1 (en) 1996-04-11
PT787007E (pt) 2002-07-31
TW410157B (en) 2000-11-01
DE69525060D1 (de) 2002-02-21
FI971245A0 (fi) 1997-03-25
HK1000552A1 (en) 2002-06-07
AU692608B2 (en) 1998-06-11
EP0787007B1 (de) 2002-01-16
MX9702398A (es) 1997-06-28
KR100424403B1 (ko) 2004-05-20
DK0787007T3 (da) 2002-04-22
JP4234197B2 (ja) 2009-03-04
IL115293A0 (en) 1995-12-31
NZ293763A (en) 1999-02-25

Similar Documents

Publication Publication Date Title
MY124151A (en) Epothilone derivatives
EP2123665A3 (de) Inhibitoren des Interleukin-1$g(b) Konversionsenzyms
EP1045635A4 (de) Klonierung von spenderkernen differentiierter fötaler und adulter zellen
ATE328067T1 (de) Isolierung von mesenchymalen stammzellen und deren verwendung
DE69731955D1 (de) Kombination von saurer protease-enzyme und saure puffers und ihre verwendung
EP0923308A4 (de)
UA29421C2 (uk) Спосіб виділення фактора vііі з інших білків в плазмі крові
CA2176494A1 (en) Purification of Hemoglobin
ATE157907T1 (de) Adsorbierende zusammenstellungen und herstellungsmethode
ATE211916T1 (de) Entzündungshemmende faktor, methode seiner isolation und verwendung
ATE462782T1 (de) Endothelstammzellen, populationen, isolierungsverfahren und verwendung davon
NO951570D0 (no) Anti-inflammatorisk faktor, fremgangsmåte for isolering derav og anvendelse
AU1828388A (en) Promoters for the expression of foreign dna in methylotrophic bacteria, the obtaining thereof and the use thereof
ATE416257T1 (de) Promotoren für wachstums-differenzierungsfaktoren und deren verwendung
CA2029201A1 (en) Process for purifying b pertussis antigens
MY117908A (en) Anti-inflammatory factor, method of isolation, and use
AU5695598A (en) Method for cross flow microfiltration of microalgae in the absence of flocculating agents
ES2168095T3 (es) Inhibidores de neutrofilos procedentes de nematodos.
FR2657260B1 (fr) Procede et composition permettant de purifier l'amphotericine b..
FI952292A7 (fi) Menetelmä kiinteiden materiaalien erottamiseksi mikro-organismeista
BR9611904A (pt) Dioxidos de ditiazol
WO2000069898A3 (en) Molecular interactions in allergy cells
ATE95188T1 (de) Zellulaere amphipatische proteine in aggregierten formen und verfahren zur herstellung und reinigung diese proteine.
DK600187D0 (da) Fremgangsmaade til at fremme udskillelse af amylolytiske enzymer fra bakterier samt ved fremgangsmaaden opnaaede enzymer
IT8820916A0 (it) Procedimento ed impianto per la coltura di microorganismi.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee